Acumen Pharmaceuticals Inc (US: ABOS) — Healthcare · Share Price, Chart & Market Data
About: Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate Sabirnetug (ACU193), a recombinant humanized immunoglobulin gamma 2, which has completed the INTERCEPT-AD phase 1 clinical trial and in ALTITUDE-AD phase 2 clinical trial to target soluble amyloid-beta oligomers. It has a collaboration and license agreement with Halozyme, Inc. for the development of a subcutaneous formulation of Sabirnetug. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Newton, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.57 (-3.75%)
ABOSAcumen Pharmaceuticals Inc
Loading watchlist status…
Trade ABOS now
Acumen Pharmaceuticals Inc share price
ABOS price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 11:14 am GMT+0
ABOS price performance
-5.861%
5D
13.717%
1M
27.228%
YTD
149.515%
1Y
ABOS price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 11:14 am GMT+0
ABOS details
ABOS Market Signals